Multidisciplinary effort boosts the George Washington University COVID-19 vaccine clinical trial. And when it comes to enrollment successes, Magnus points to GW's storied history in forming bonds with the local community. "The context of the HIV Prevention Network is so important and the relationships that helped us build," she says. "There’s nothing we can do by ourselves, it's really hand-in-hand with the community. We're fortunate that for decades we’ve had these connections. We trust them and they trust us, it’s open and transparent." Continue reading this article to see the process of setting up the site, the power of volunteers, and many more aspects of starting the COVID-19 Vaccine Clinical Trial.
A Game Winning Shot
Latest News
The GW VRU is proud to announce our newest publication to describe the development of a new Na-GST-1/Alhydrogel hookworm vaccine. This study showed promising results and can be read at the link below:
You are invited to attend the first featured presentation in the "State-of-the-Art Topics in Vaccinology" Seminar Series on Tuesday January 28, 2025 at 2 pm. by Dr. Nadine Rouphael, Executive Director of the Hope Clinic at the Emory Vaccine Center.
FDA Approves Abrysvo for Adults 18-59 at Increased Risk for RSV